Digital Diagnostics

Digital Diagnostics is a leading AI diagnostics company with a mission to transform the quality, accessibility, and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist, and computer engineer, the company has developed a patented biomarker-based approach that enables the creation of autonomous algorithms capable of making clinical decisions without human intervention. Digital Diagnostics and its flagship product, IDx-DR, are FDA-authorized autonomous AI systems for diagnosing diabetic retinopathy and diabetic macular edema, demonstrating that intelligent diagnostic platforms can be used safely, efficiently, and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics is paving the way for automated diagnosis to become a new standard of care, significantly advancing the democratization of healthcare.